Peramivir Specifications

Product Name	C15H28N4O4
CAS Registry Number	330600-85-6
Molecular Formula	C15H28N4O4
Molecular Weight	324.8 g/mol
Purity	99 %
Appearance	White crystalline solid
Package	1kg-25kg
Shelf life	2 years
Functions	Treating Influenza A and B

Peramivir Description

Peramivir is an antiviral drug developed by BioCryst Pharmaceuticals for the treatment of influenza. It is selective for influenza neuraminidase over bacterial, mammalian, and other viral neuraminidases. Pretreatment with peramivir (10-100 mg/kg) protects mice against lethal influenza infections. It also increases survival in ferrets infected intranasally with avian influenza type A H5N1 when injected intramuscularly after infection. Formulations containing peramivir have been used to treat influenza.

Peramivir is an antiviral agent developed by Biocryst Pharmaceuticals to treat influenza A/B.

[caption id="attachment_7503" align="alignnone" width="640"] peramivir[/caption]

Peramivir Applications

• Pharmaceutical anti-flu drugs

Reference:

1. Young, D., Fowler, C., and Bush, K. RWJ-270201 (BCX-1812): A novel neuraminidase inhibitor for influenza. Philos. Trans. R. Soc. Lond. B Biol. Sci 356(1416), 1905-1913 (2001).
2. Yun, N.E., Linde, N.S., Zacks, M.A., et al. Injectable peramivir mitigates disease and promotes survival in ferrets and mice infected with the highly virulent influenza virus, A/Vietnam/1203/04 (H5N1). Virology 374(1), 198-209 (2008).